0.841
Creative Medical Technology Holdings Inc Stock (CELZ) Forecast
The Creative Medical Technology Holdings Inc (CELZ) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.6376, representing a +94.72% increase from the current price of $0.841. The highest analyst price target is $2.6289, and the lowest is $0.6463.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CELZ Price Target
Average 2.0091
(+138.90% Upside)
Is Creative Medical Technology Holdings Inc (CELZ) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.26 | Neutral |
| STOCH(9,6) | 10.30 | Buy |
| STOCHRSI(14) | 2.3454 | Buy |
| MACD(12,26) | -0.0467 | Sell |
| ADX(14) | 16.53 | Neutral |
| William %R | -90.87 | Buy |
| CCI(14) | -152.28 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9037
Sell
|
0.8941
Sell
|
| MA20 |
0.9258
Sell
|
0.9314
Sell
|
| MA50 |
1.0283
Sell
|
1.0335
Sell
|
| MA100 |
1.2925
Sell
|
1.2558
Sell
|
| MA200 |
1.6708
Sell
|
1.6737
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CELZ could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CELZ, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.26 indicates that CELZ is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.3 indicates that CELZ is oversold. This indicates that CELZ price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.3454 indicates that CELZ is oversold. This suggests that CELZ price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.53 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -152.28 indicates that CELZ is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CELZ price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Creative Medical Technology Holdings Inc financial reports and earnings history, Creative Medical Technology Holdings Inc (CELZ) stock could reach $4.7644 by 2030, $3.7731 by 2040 and $4.8412 by 2050. See the projected annual prices until 2050 of the Creative Medical Technology Holdings Inc stock below:
- Creative Medical Technology Holdings Inc (CELZ) is expected to reach an average price of $2.6026 in 2035, with a high prediction of $3.1349 and a low estimate of $2.4854. This indicates an $209.47% rise from the last recorded price of $0.841.
- Creative Medical Technology Holdings Inc (CELZ) stock is projected to chart a bullish course in 2040, with an average price target of $1.791, representing an $112.96% surge from its current level. The forecast ranges from a conservative $1.4981 to a sky-high $3.7731.
- Our analysts predict Creative Medical Technology Holdings Inc (CELZ) to jump 76.87% by 2045, soaring from $0.2252 to an average price of $1.4874, potentially reaching $2.7169. While $0.2252 is the low estimate, the potential upside is significant.
- Creative Medical Technology Holdings Inc (CELZ) stock is expected to climb by 2050, reaching an average of $4.7231, a $461.60% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.8412 and $4.6703, respectively, highlighting the market's uncertainty.
Creative Medical Technology Holdings Inc Stock (CELZ) Year by Year Forecast
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2026
The predicted value for Creative Medical Technology Holdings Inc (CELZ) in 2026 is set at an average of $2.4036. Estimates vary from a peak of $4.7199 to a trough of $0.0874, indicating an +185.81% surge from the present price of $0.841.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.8568 | $0.6463 | $2.6289 | +1.88% |
| December, 2026 | $0.5974 | $0.0874 | $1.0974 | -28.97% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Creative Medical Technology Holdings Inc (CELZ) is $2.0144, with a high forecast of $3.9309 and a low forecast of $0.0979. This indicates an +139.53% increase from the last price of $0.841.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3479 | $0.0979 | $0.8725 | -58.63% |
| February, 2027 | $2.4485 | $0.2106 | $3.9309 | +191.14% |
| March, 2027 | $0.3017 | $0.2718 | $2.9411 | -64.13% |
| April, 2027 | $0.2667 | $0.1243 | $0.7043 | -68.28% |
| May, 2027 | $0.4245 | $0.2651 | $0.4872 | -49.52% |
| June, 2027 | $0.489 | $0.4619 | $0.5067 | -41.86% |
| July, 2027 | $0.4285 | $0.4361 | $0.3784 | -49.04% |
| August, 2027 | $0.4598 | $0.4602 | $0.4373 | -45.32% |
| September, 2027 | $0.7337 | $0.627 | $0.6095 | -12.76% |
| October, 2027 | $0.6747 | $0.7194 | $0.6838 | -19.77% |
| November, 2027 | $0.6883 | $0.7159 | $0.6938 | -18.15% |
| December, 2027 | $0.7143 | $0.7407 | $0.7104 | -15.07% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2028
In 2028, Creative Medical Technology Holdings Inc (CELZ) is projected to reach an average price of $3.1994, with a high projection of $6.0255 and a low estimate of $0.3733. This indicates an +280.42% rise from the last price of $0.841.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5472 | $0.5622 | $0.6474 | -34.94% |
| February, 2028 | $0.4366 | $0.3733 | $0.5095 | -48.08% |
| March, 2028 | $0.5811 | $0.514 | $0.5222 | -30.91% |
| April, 2028 | $0.3418 | $0.5831 | $0.5231 | -59.36% |
| May, 2028 | $0.4172 | $0.4329 | $0.3553 | -50.39% |
| June, 2028 | $0.5969 | $0.4694 | $0.4487 | -29.03% |
| July, 2028 | $3.9064 | $3.0859 | $5.6958 | +364.50% |
| August, 2028 | $4.387 | $3.9092 | $5.7417 | +421.64% |
| September, 2028 | $3.7475 | $3.2049 | $4.6296 | +345.60% |
| October, 2028 | $3.9408 | $3.5128 | $6.0255 | +368.58% |
| November, 2028 | $3.4113 | $3.3413 | $4.186 | +305.63% |
| December, 2028 | $3.5395 | $3.2592 | $3.7895 | +320.86% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2029
The 2029 price forecast for Creative Medical Technology Holdings Inc Stock (CELZ) is $5.5972 on average, with a high prediction of $9.3732 and a low estimate of $1.8212. This represents an +565.54% increase from the previous price of $0.841.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.7251 | $3.2245 | $3.7951 | +342.93% |
| February, 2029 | $3.5657 | $3.4777 | $5.6577 | +323.99% |
| March, 2029 | $3.3312 | $3.2683 | $3.6775 | +296.10% |
| April, 2029 | $3.3739 | $3.0141 | $3.5666 | +301.17% |
| May, 2029 | $4.3099 | $3.092 | $9.3732 | +412.48% |
| June, 2029 | $3.4305 | $3.4085 | $4.9552 | +307.91% |
| July, 2029 | $3.4338 | $3.3697 | $4.0165 | +308.30% |
| August, 2029 | $2.6842 | $2.0343 | $3.5963 | +219.17% |
| September, 2029 | $2.6848 | $2.3923 | $3.1059 | +219.24% |
| October, 2029 | $2.658 | $2.0653 | $3.488 | +216.05% |
| November, 2029 | $2.4185 | $2.1886 | $3.0359 | +187.58% |
| December, 2029 | $3.4346 | $1.8212 | $3.5717 | +308.40% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2030
Creative Medical Technology Holdings Inc Stock (CELZ) is expected to reach an average price of $3.5427 in 2030, with a high forecast of $6.1372 and a low forecast of $0.9483. This signifies an +321.25% surge from the last price of $0.841.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2123 | $2.167 | $4.7644 | +281.96% |
| February, 2030 | $1.8679 | $1.6103 | $3.3103 | +122.10% |
| March, 2030 | $1.5234 | $1.1678 | $1.8655 | +81.14% |
| April, 2030 | $1.6566 | $1.344 | $2.1413 | +96.98% |
| May, 2030 | $4.6372 | $1.7292 | $6.1372 | +451.39% |
| June, 2030 | $2.1277 | $1.8677 | $5.9924 | +153.00% |
| July, 2030 | $1.2309 | $0.9483 | $2.1904 | +46.36% |
| August, 2030 | $1.4115 | $1.1136 | $1.4615 | +67.83% |
| September, 2030 | $1.4647 | $1.2067 | $1.8947 | +74.16% |
| October, 2030 | $1.9652 | $1.3998 | $2.1773 | +133.68% |
| November, 2030 | $2.0858 | $1.6433 | $3.578 | +148.01% |
| December, 2030 | $2.499 | $1.9485 | $3.3111 | +197.14% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):